[1] |
龚西騟,丁华野. 乳腺病理学[M]. 北京:人民卫生出版社,2009:241-258.
|
[2] |
Tavassoli FA, Devilee P. WHO classification of tumours:pathology and genetics of tumours of the breast and female genital organs [M]. Lyon: IARC Press,2003:60-73.
|
[3] |
牛昀.乳腺导管内癌的基础与临床研究:一个应倍加重视的领域[J/CD].中华乳腺病杂志:电子版,2008,2(6):626-633.
|
[4] |
Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO classification of tumours of the breast[M]. Lyon: IARC Press,2012:95-98.
|
[5] |
Altintas S, Lambein K, Huizing MT, et al. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast:a clinicopathologic study[J]. Breast J,2009,15(2):120-132.
|
[6] |
姜越, 马文锋, 李翔. 乳腺导管内癌:附123 例(125 侧)报告[J]. 中国普通外科杂志,2009,18(5):431-434.
|
[7] |
刘冰天,高海东,张凯,等. 乳腺导管内癌伴微浸润和粉刺样坏死的临床病理研究[J]. 中国现代普通外科进展,2011,14(8):606-609.
|
[8] |
俸瑞发,邵志敏,宫晓洁. 乳腺导管原位癌的诊断和治疗(附371 例报道) [J]. 肿瘤防治杂志, 2005, 12(8):62l-622.
|
[9] |
Ellsworth RE,Ellsworth DL,Love B,et al.Correlation of levels and patterns of genomic instability with histological grading of DCIS[J].Ann Surg Oncol,2007,14(11):3070-3077.
|
[10] |
Meijnen P,Peterse JL,Antonini N,et al.Immunohistochemical categorisation of ductal carcinoma in situ of the breast[J].Br J Cancer,2008,98(1):137-142.
|
[11] |
Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy[J]. J Natl Cancer Inst,2003,95(22):1692-1702.
|
[12] |
连臻强,张江宇,王颀,等. 乳腺导管内癌及其微浸润癌病理和生物学指标表达差异的临床意义[J/CD]. 中华乳腺病杂志:电子版,2011,5(4):419-425.
|
[13] |
Sue GR, Lannin DR, Killelea B, et al. Predictors of microinvasion and its prognostic role in ductal carcinoma in situ[J]. Am J Surg,2013,206(4):478-481.
|
[14] |
Ballehaninna UK, Chamberlain RS. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast[J]. Clin Breast Cancer,2013,13(5):350-358.
|
[15] |
Filippakis GM, Zografos G. Contraindications of sentinel lymph node biopsy: are there any really? [J]. World J Surg Oncol,2007,5(1):10.
|
[16] |
孙晓, 王永胜, 周正波, 等. 乳腺导管内癌前哨淋巴结活检术的临床意义[J]. 中华内分泌外科杂志,2010,4(1):28-31.
|
[17] |
Zavagno G, Belardinelli V, Marconato R, et al. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion[J]. Breast,2007,16(2):146-151.
|
[18] |
Sakr R, Barranger E, Antoine M, et al. Ductal carcinoma in situ: value of sentinel lymph node biopsy[J]. J Surg Oncol,2006,94(5):426-430.
|
[19] |
Intra M, Brito JAD, Soteldo J, et al. Sentinel lymph node biopsy in intraductal carcinoma of the breast with microinvasion[J]. Int J Cancer Res,2005,1(1):1-4.
|
[20] |
Sakorafas GH, Tsiotou AG. Ductal carcinoma in situ (DCIS)of the breast: evolving perspectives [J]. Cancer Treat Rev,2000,26 (2):103-125.
|
[21] |
Colina Ruizdelgado F, Pilas Pérez M, Lora Pablos D.Analysis of the breast cancer survival in a public hospital during the period 1999-2008[ J]. Rev Esp Salud Publica,2012,86(6):589-600.
|
[22] |
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy, and lumpectomy plus irradiation for the treatment invasive breast cancer[J]. N Engl J Med, 2002, 347(16):1233-1241.
|
[23] |
Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast[J]. J Clin Oncol,2006,24(7):1031-1036.
|
[24] |
Lee DY,Lewis JL,Wexelman BA, et al. The consequence of undertreatment of patients treated with breast conserving therapy for ductal carcinoma in-situ [J]. Am J Surg, 2013,206(5):790-797.
|
[25] |
Vicini FA, Shaitelman S, Wilkinson JB, et al. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy[J]. Breast J, 2013,19(4):365-373.
|
[26] |
Silverstein MJ. The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast[J]. Am J Surg,2003,186 (4):337-343.
|
[27] |
于泳, 方志沂, 刘君. 123 例乳腺导管内癌临床特点和远期疗效[J]. 天津医科大学学报,2003,9(2):180-182.
|
[28] |
Okumura Y, Yamamoto Y, Zhang Z, et al. Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion[J]. BMC Cancer,2008,8(1):287.
|
[29] |
Padmore RF, Fowble B, Hoffman J, et al. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience[J]. Cancer,2000,88(6):1403-1409.
|
[30] |
Silver SA, Tavassoli FA. Mammary ductal carcinoma in situ with microinvasion[J]. Cancer,1998,82(12):2382-2390.
|
[31] |
周雷,王岩,宋新,等. 乳腺导管内癌的临床病理特点与治疗[J].中华医学杂志,2005,85(43):3025-3038.
|